Comment on

• Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.

  Bozzette SA, Joyce G, McCaffrey DF, Leibowitz AA, Morton SC, Berry SH, Rastegar A, Timberlake D, Shapiro MF, Goldman DP; HIV Cost and Services Utilization Study Consortium. Bozzette SA, et al. N Engl J Med. 2001 Mar 15;344(11):817-23. doi: 10.1056/NEJM200103153441107. N Engl J Med. 2001. PMID: 11248159
• The cost effectiveness of combination antiretroviral therapy for HIV disease.

  Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ. Freedberg KA, et al. N Engl J Med. 2001 Mar 15;344(11):824-31. doi: 10.1056/NEJM200103153441108. N Engl J Med. 2001. PMID: 11248160